Abnormal Localization and Accumulation of FLT3-ITD, a Mutant Receptor Tyrosine Kinase Involved in Leukemogenesis

Publisher： Karger

E-ISSN： 1422-6421|188|1-2|225-235

ISSN： 1422-6405

Source： Cells Tissues Organs, Vol.188, Iss.1-2, 2008-02, pp. : 225-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia

By  

Current Pharmaceutical Design, Vol. 10, Iss. 16, 2004-06 ,pp. : 1867-1883

Bentham Science Publishers

Access to resources Recommend Favorite

Novel FLT3 tyrosine kinase inhibitors

By Levis Mark   Small Donald  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 12, 2003-12 ,pp. : 1951-1962

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule FLT3 Tyrosine Kinase Inhibitors

By  

Current Pharmaceutical Design, Vol. 10, Iss. 11, 2004-04 ,pp. : 1183-1193

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment with FLT3 inhibitor in patients with FLT3-mutated acute myeloid leukemia is associated with development of secondary FLT3–tyrosine kinase domain mutations

By Alvarado Yesid   Kantarjian Hagop M.   Luthra Rajyalakshmi   Ravandi Farhad   Borthakur Gautam   Garcia-Manero Guillermo   Konopleva Marina   Estrov Zeev   Andreeff Michael   Cortes Jorge E.  

Cancer, Vol. 120, Iss. 14, 2014-07 ,pp. : 2142-2149

Blackwell Publishing

Access to resources Recommend Favorite

Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD–negative acute myeloid leukemia

By Qu Shuang   Liu Bin   Guo Xiaoling   Shi Hongshun   Zhou Meifeng   Li Li   Yang Shulan   Tong Xiuzhen   Wang Haihe  

Cancer, Vol. 120, Iss. 14, 2014-07 ,pp. : 2130-2141

Blackwell Publishing

Access to resources Recommend Favorite